News

LifeNet Health Announced that Rony Thomas has Resigned

LifeNet Health announced that Rony Thomas has resigned as President and Chief Executive Officer and as a member of its Board of Directors, effective November 13, 2026.

Mr. Thomas led LifeNet Health since 2004. During his tenure, the organization grew into a global leader in organ and tissue procurement and regenerative medicine.

“On behalf of the Board, I thank Rony for his years of service to LifeNet Health and its mission,” said Dr. John Herre, Chairman of the Board. “We wish him well in his future endeavors.”

“After more than two decades of service, I have stepped down as President and Chief Executive Officer of LifeNet Health,” said Rony Thomas. “It has been a privilege to lead an organization so committed to honor the gift of donation and to improve the lives of patients around the world. I am proud of what the entire team, community and partners have accomplished during this time. I wish the organization continued success. I look forward to my next chapter.”

Douglas B. Wilson will continue to serve as Interim Chief Executive Officer. LifeNet Health’s operations and its commitment to donors, families, and patients continue without interruption.

Read more here.

Recent News

11/17/2026

LifeNet Health Announced that Rony Thomas has Resigned

LifeNet Health announced that Rony Thomas has resigned as President and Chief Executive Officer and as a member of its Board of Directors, effective November 13, 2026. Mr. Thomas led LifeNet Health since 2004. During his tenure, the organization grew into a global leader in organ and tissue procurement and regenerative medicine. “On behalf of …

11/10/2026

Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System

Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google Ventures), Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors. The Series …

11/04/2026

$6 Million in Philanthropic Gifts Establishes UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund. This fund will provide long-term support for the UVA SPARK Innovative Medicines program, helping accelerate promising discoveries toward new treatments and cures. “The mission of the UVA Manning Institute of …